The global healthcare landscape is witnessing unprecedented momentum in neurodegenerative disease research, with the Amyotrophic Lateral Sclerosis Treatment Market emerging as a beacon of hope for millions worldwide. This devastating motor neuron disease, affecting approximately 200,000 individuals globally, has catalyzed a surge in pharmaceutical innovation and investment, fundamentally reshaping therapeutic possibilities for patients facing this… Read.